Results 161 to 170 of about 20,867 (266)
Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7048-7057, August 2026.ABSTRACT Aims To compare 1‐year psychiatric outcomes after GLP‐1 receptor agonist (GLP‐1 RA) versus sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) initiation in patients with type 2 diabetes and treated depression. Materials and Methods We conducted a retrospective active‐comparator, new‐user cohort study using electronic health records from the ...
Yu Chang +3 more
wiley +1 more source
GLP-1RA- and Incretin-Based Therapies Within Lifestyle Interventions for Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis. [PDF]
NutrientsBruna-Mejias A +7 more
europepmc +1 more source
HbA1c kinetics as a prognostic marker of ophthalmic risk in GLP-1 receptor agonist therapy. [PDF]
Metabol OpenMargoni A +2 more
europepmc +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7280-7290, August 2026.ABSTRACT Aims While being recognised for stimulating pancreatic insulin secretion, GIP and GLP‐1 exert various extrapancreatic effects relevant in the context of incretin‐based therapies. Here, we evaluated the extrapancreatic effects of GIP and GLP‐1, separately and combined, on postprandial physiology in totally pancreatectomised individuals ...
Liva S. L. Krogh +8 more
wiley +1 more source
Psychosocial Outcomes in Telemedicine and Long-Acting Incretin-Specific Behavioral Intervention. [PDF]
Obes Sci PractHeinberg LJ +7 more
europepmc +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7430-7442, August 2026.ABSTRACT Aims To investigate the association of post‐oral glucose tolerance test (OGTT) hypoglycaemia with clinical features, incident diabetes and mortality. Materials and Methods This population‐based cohort study included 2924 adults (median age 49 years, 1680 women) without known diabetes who underwent a 75‐g OGTT as part of the Di@bet.es Study ...
Tomás González‐Vidal +14 more
wiley +1 more source
Tirzepatide in Obesity-Related Obstructive Sleep Apnea: Beyond Weight Loss Toward Disease Modification? [PDF]
Life (Basel)Mihălțan FD, Borcea CI, Constantin AA.
europepmc +1 more source
Does lifestyle intervention lower clinically significant cognitive impairment risk?
Alzheimer's &Dementia, Volume 22, Issue 7, July 2026.Abstract INTRODUCTION Multidomain lifestyle interventions have been demonstrated to benefit cognitive function but it is unknown whether they reduce risk for clinically significant cognitive impairment sCI (mild cognitive impairment or dementia). METHODS The Action for Health in Diabetes administered repeated cognitive assessments in adults who had ...
Mark A. Espeland +16 more
wiley +1 more source